电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

protein ariadne-2 homolog (ARIH2) Peptide

ARIH2 适用: 人 宿主: 合成 BP, WB, IHC
产品编号 ABIN973415
发货至: 中国

Quick Overview for protein ariadne-2 homolog (ARIH2) Peptide (ABIN973415)

抗原

ARIH2 (protein ariadne-2 homolog (ARIH2))

宿主

资源

  • 4
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • 产品特性

    This is a synthetic peptide designed for use in combination with anti-ARIH2 antibody (Catalog #: ARP34418_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    纯化方法

    Purified
  • 应用备注

    Each Investigator should determine their own optimal working dilution for specific applications.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    浓度

    1 mg/mL

    缓冲液

    Final peptide concentration is 1 mg/mL in PBS.

    注意事项

    Avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    ARIH2 (protein ariadne-2 homolog (ARIH2))

    背景

    ARIH2 might act as an E3 ubiquitin-protein ligase, or as part of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, such as UBE2L3/UBCM4, and then transfers it to substrates.

    Alias Symbols: ARI2, FLJ10938, FLJ33921, TRIAD1

    Protein Interaction Partner: UBE2L3,ARAP1,BUB1,CBR3,DLST,EEF1A1,EEF1G,EML4,ENSA,IL4R,KAT5,KCNQ2,KIAA1377,PPP2R1A,PTN,RPL8,SCAMP2,SGCE,SLC1A6,TP53,UBE2L3,UGP2,UTP14A,WDR91,ARAP1,BUB1,CBR3,DLST,EEF1A1,EEF1G,EML4,ENSA,GFI1,IL4R,KAT5,KCNQ2,KIAA1377,LOC147791,PPP2R1A,PTN,RPL8,SCAMP2,SGCE,SLC1A6,TP53,UBE2L3,UGP2,UTP14A,WDR91

    Protein Size: 493

    分子量

    58 kDa

    基因ID

    10425

    NCBI登录号

    NM_006321, NP_006312

    UniProt

    O95376
You are here:
Chat with us!